Amendment #1 -Q & A -Biosimilar and Interchangeable Continuing Education · FederalPipeline
Amendment #1 -Q & A -Biosimilar and Interchangeable Continuing Education
Combined Synopsis/Solicitation from Food and Drug Administration, solicitation 75F40125R00056. Responses due Mar 17, 2025. NAICS 611430. Listed on SAM.gov.